Home › Research › Long-term cohort studies
Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study
Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R, Alzheimer's Disease Neuroimaging Initiative.. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2012-12-08
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Greater intracranial volume (ICV) has been associated with less severe Alzheimer's disease (AD) symptoms at a given level of cerebral pathology. In this study we examine whether ICV modulates the association between clinical disease progression on the one hand and brain atrophy or the apolipoprotein E genotype on the other. Methods Six hundred seventy-four subjects were studied from the AD Neuroimaging Initiative (ADNI).
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 204 participants. This longitudinal ADNI study of 674 subjects examined whether intracranial volume modifies the link between clinical progression and brain atrophy or apolipoprotein E genotype. It is an observational study, so it cannot show that brain size protects against or treats Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Guo, L. H., Alexopoulos, P., Wagenpfeil, S., Kurz, A., Perneczky, R., & Alzheimer's Disease Neuroimaging Initiative. (2013). Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1016/j.jalz.2012.10.002
Vancouver
Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R, Alzheimer's Disease Neuroimaging Initiative. Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2013. doi:10.1016/j.jalz.2012.10.002. PMID: 23232272.
BibTeX
@article{guo2013-23232272,
author = {Guo, L. H. and Alexopoulos, P. and Wagenpfeil, S. and Kurz, A. and Perneczky, R. and {Alzheimer's Disease Neuroimaging Initiative}},
title = {{Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study}},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2013},
doi = {10.1016/j.jalz.2012.10.002},
pmid = {23232272},
url = {https://doi.org/10.1016/j.jalz.2012.10.002}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In this study we examine whether ICV modulates the association between clinical disease progression on the one hand and brain atrophy or the apolipoprotein E genotype on the other.
- Methods Six hundred seventy-four subjects were studied from the AD Neuroimaging Initiative (ADNI).
- Subjects included 204 controls, 144 patients with AD dementia, and 326 with amnestic mild cognitive impairment (aMCI).
- Longitudinal analyses were conducted applying generalized estimating equations to examine the influence of ICV on clinical deterioration and atrophy progression.
Why it matters
This longitudinal ADNI study of 674 subjects examined whether intracranial volume modifies the link between clinical progression and brain atrophy or apolipoprotein E genotype. It is an observational study, so it cannot show that brain size protects against or treats Alzheimer's disease.
Study details
- Study designlongitudinal study
- Participants204
- Evidence strengthModerate
How this study scored 55/100
Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 53 of the 96 points we could judge it on, which is 55 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2013 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 204 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 60 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.0 citations a year over 15 year(s) since 2013 |
| Impact for its field and year | 2 / 6 | Cited 2.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 1 / 4 | Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 2 / 3 | Imperial College London: institution h-index 1,744 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 23232272) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 53 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 53 of the 96 points we could judge it on is 55 out of 100. |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.